Delving into the Latest Updates on Suhe Granules with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Digestive System Disorders

Active Indication

Gastritis, Atrophic

Inactive Indication-

Originator Organization

Beijing University of Traditional Chinese Medicine

Chongqing Juqi Nuomei Pharmaceutical Co., Ltd

Active Organization

Chongqing Juqi Nuomei Pharmaceutical Co., Ltd

Beijing University of Traditional Chinese Medicine

Inactive Organization-

License Organization-

Drug Highest PhasePhase 2

First Approval Date-

Regulation-

Login to view timeline

Primary Objective: To evaluate the efficacy of Suhe granules in the treatment of chronic atrophic gastritis. Secondary Objective: To evaluate the safety of Suhe granules in the treatment of chronic atrophic gastritis. To explore the optimal dosage of Suhe granules for the treatment of chronic atrophic gastritis. To explore the disease progression (PD) characteristics of Suhe granules in the treatment of chronic atrophic gastritis.

Start Date-

Sponsor / Collaborator

Beijing University of Traditional Chinese Medicine

[+1]

100 Clinical Results associated with Suhe Granules

Login to view more data

100 Translational Medicine associated with Suhe Granules

Login to view more data

100 Patents (Medical) associated with Suhe Granules

Login to view more data

100 Deals associated with Suhe Granules

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Gastritis, Atrophic	Phase 2	China	Chongqing Juqi Nuomei Pharmaceutical Co., Ltd	06 Feb 2026
Gastritis, Atrophic	Phase 2	China	Beijing University of Traditional Chinese Medicine	06 Feb 2026